Provided by Tiger Fintech (Singapore) Pte. Ltd.

Insmed

73.44
+1.442.00%
Pre-market: 72.49-0.9500-1.29%04:13 EDT
Volume:2.44M
Turnover:176.98M
Market Cap:13.29B
PE:-13.18
High:73.45
Open:71.71
Low:70.30
Close:72.00
Loading ...

Insmed Continues To Anticipate Full-year 2025 Global Arikayce Revenues In The Range Of $405M-$425M, Representing Between 11% And 17% Year-over-year Growth Compared To 2024

Benzinga
·
20 Feb

Insmed Q4 2024 GAAP EPS $(1.32) Misses $(1.17) Estimate, Sales $104.44M Beat $101.79M Estimate

Benzinga
·
20 Feb

BRIEF-Insmed Q4 Revenue USD 104.4 Million Vs. IBES Estimate USD 102.8 Million

Reuters
·
20 Feb

Insmed Q4 Revenue USD 104.4 Million VS. Ibes Estimate USD 102.8 Million

THOMSON REUTERS
·
20 Feb

Insmed Outlook FY Revenue USD 405-425 Million

THOMSON REUTERS
·
20 Feb

Insmed Q4 Net Income USD -235.5 Million VS. Ibes Estimate USD -202.7 Million

THOMSON REUTERS
·
20 Feb

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
20 Feb

Cantor Fitzgerald biotech analyst holds an analyst/industry conference call

TIPRANKS
·
20 Feb

Will Insmed Incorporated’s (INSM) New Drugs be Able to Peak Sales?

Insider Monkey
·
19 Feb

Insmed Is Maintained at Overweight by Wells Fargo

Dow Jones
·
19 Feb

Insmed Incorporated : Wells Fargo Raises Target Price to $107 From $85

THOMSON REUTERS
·
19 Feb

Mizuho Adjusts Price Target on Insmed to $96 From $88, Keeps Outperform Rating

MT Newswires Live
·
18 Feb

Will These 5 Biotech Stocks Surpass Q4 Earnings Forecast?

Zacks
·
17 Feb

Countdown to Insmed (INSM) Q4 Earnings: Wall Street Forecasts for Key Metrics

Zacks
·
17 Feb

Insmed (INSM) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release

Zacks
·
13 Feb

Insmed Is Maintained at Buy by Stifel

Dow Jones
·
11 Feb

Stifel Nicolaus Remains a Buy on Insmed (INSM)

TIPRANKS
·
11 Feb

Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK), Insmed (INSM) and IQVIA Holdings (IQV)

TIPRANKS
·
11 Feb

Insmed to Host Fourth-Quarter and Full-Year 2024 Financial Results Conference Call on Thursday, February 20, 2025

PR Newswire
·
10 Feb

Have Insiders Sold Insmed Shares Recently?

Simply Wall St.
·
09 Feb